Companies We’re Proud to Have Helped Build

adMare has helped build more than 25 life sciences companies across Canada that have attracted more than $1.4B of investment, employ more than 900 Canadians, and have a combined worth of over $3B.

Click on the logo to find more information on our portfolio companies.

Abdera Therapeutics logo


Abdera Therapeutics Inc. is a precision oncology company focused on developing next-generation effective targeted alpha radiation therapies (TATs) for patients with relapsed, refractory and metastatic cancers. For more information visit:

ImStar Therapeutics

ARNA Therapeutics is a private biotechnology company developing new therapeutic approaches to treat patients with neurodegenerative diseases. For more information visit: 

Bellus Health logo

Bellus Health

Bellus Health is developing BLU-5937, a P2X3 antagonist, to help people with chronic cough and other afferent hypersensitization-related disorders. For more information visit:

Bright Angel Therapeutics

Bright Angel Therapeutics is a pre-clinical stage biotechnology company focused on the development of novel therapeutics for the treatment of drug-resistant and life-threatening fungal infections. For more information visit:

Encyle Therapeutics logo

Encycle Therapeutics

Encycle Therapeutics was created to develop a unique platform technology that enables the rapid synthesis of drug-like macrocycles or membrane-permeable nacellins. The company was acquired by Zealand Pharma in 2019. For more information:

Epigene Therapeutics Inc. logo

Epigene Therapeutics

Epigene Therapeutics was established to advance novel, orally bioavailable epigenetic modulators for the targeted treatment of cancer.

Eupraxia Pharmaceuticals

Eupraxia is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to currently approved drugs. For more information visit:

Find Therapeutics logo

Find Therapeutics

Find Therapeutics is a discovery and development company dedicated to the development of the next generation of GPCR allosteric modulators to treat rare diseases. For more information visit:

Flosonics Medical

Flosonics Medical is a medical device company focused on developing non-invasive sensors to improve the management of critically-ill patients. For more information visit:

Forus Therapeutics logo

Forus Therapeutics

FORUS Therapeutics is a biopharmaceutical company dedicated to advancing differentiated, novel medicines for hematologic malignancies and other forms of cancer. For more information visit:

Inversago Pharma logo

Inversago Pharma

Inversago Pharma is a clinical-stage, biotech company aiming to provide new treatment options that improve the lives of patients affected by metabolic conditions such as Prader-Willi Syndrome (PWS), non-alcoholic steatohepatitis (NASH), type 1 diabetes (T1D) and diabetic nephropathy. For more information visit:

Jenthera Therapeutics

Jenthera Therapeutics is offers a new CRISPR technology by directly addressing the inherent limitations of current CRISPR methodologies. For more information visit:

Kairos Therapeutics logo

Kairos Therapeutics

Kairos Therapeutics was a biopharmaceutical company that developed a proprietary next-generation antibody-drug conjugate platform. It was merged with Zymeworks in 2016.

Kalgene Pharmaceuticals logo

KalGene Pharmaceuticals

KalGene is a biotechnology company developing precision medicine therapeutics designed to slow the progression of Alzheimer’s disease with an antibody-based approach. For more information visit:

KisoJi logo


KisoJi is a privately-held next-generation antibody company developing multi-specific antibodies to improve outcomes in oncology. For more information visit:

Mesentech logo


Mesentech is a pre-clinical platform company developing innovative drugs that rebuild bone lost to disease and trauma. For more information visit:

Neurasic Therapeutics logo

Neurasic Therapeutics

Neurasic Therapeutics is a company created to advance research that aims to provide new opiate-sparing pain-relieving drugs. For more information visit:

Nexelis logo


Nexelis is an immunology-centric CRO specialized in preclinical models and clinical assay development in single and multiplex formats and sample analysis for low-, mid- and large-scale clinical testing. For more information visit:

NIMIUM Therapeutics

NIMIUM Therapeutics is a Montreal biotech focused on the development of an innovative therapeutic to treat cardiometabolic diseases. For more information visit

Precision Nanosystems logo

Precision Nanosystems

Precision Nanosystems Inc. creates innovative solutions that empower researchers to harness powerful nanotechnology to transform our understanding and treatment of diseases. For more information visit:

Sepset logo


Sepset Biosciences is a diagnostic company developing a point-of-care blood test for hospitals to identify septic patients in the emergency room (ER), and predict those who will have high risk for organ failure. For more information visit:

Sitka Biopharma logo


Sitka Biopharma is a preclinical biotechnology company focused on developing its breakthrough nanoparticle platform technology to increase absorption of drugs in difficult-to-penetrate tissues. For more information visit:

Soundbite Medical Solutions logo

SoundBite Medical Solutions

SoundBite Medicalis a medical devices company developing and commercializing proprietary wire-based devices and generator technology that delivers shockwave energy within the cardiovascular system to treat chronic total occlusions (CTO’s). For more information visit:

viDA Therapeutics

viDA Therapeutics is advancing first-in-class drugs for the treatment of autoimmune and age-related chronic inflammatory diseases. For more information visit:

Zucara logo


Zucara Therapeutics Inc. is developing the first once-daily therapeutic to prevent hypoglycemia (low blood sugar) in people with diabetes. For more information visit:

Zymeworks logo


Zymeworks Inc. is a publicly listed (NYSE: ZYME), clinical-stage, biopharmaceutical company dedicated to the discovery, development, and commercialization of next-generation multifunctional biotherapeutics, initially focused on the treatment of cancer. For more information visit: